Km | Vmax | Intrinsic Clearance (Vmax/Km) | Ks | |
---|---|---|---|---|
μM | pmol/min/pmol P450 | μl/min/pmol P450 | μM | |
MDZ 1′-hydroxylation | ||||
CYP3A4.1 | 1.9 ± 0.1 | 28.1 ± 2.8 | 14.8 ± 1.5 | 407 ± 32 |
CYP3A4.16 | 2.6 ± 0.1*** | 15.0 ± 3.5** | 5.8 ± 1.7*** | 986 ± 302* |
CYP3A4.18 | 2.0 ± 0.1 | 17.5 ± 3.2* | 8.8 ± 1.6** | 713 ± 168 |
MDZ 4-hydroxylation | ||||
CYP3A4.1 | 23.1 ± 5.2 | 12.9 ± 0.1 | 0.58 ± 0.14 | |
CYP3A4.16 | 51.5 ± 3.5*** | 11.7 ± 1.4 | 0.23 ± 0.04* | |
CYP3A4.18 | 22.3 ± 3.5 | 9.2 ± 2.0* | 0.42 ± 0.11 | |
CBZ epoxidationa | ||||
CYP3A4.1 | 21.9 ± 5.2 (Km1) | 15.5 ± 2.5 | 0.095 ± 0.018 | |
165 ± 15 (Km2) | ||||
CYP3A4.16 | 48.0 ± 3.7*** (Km1) | 11.0 ± 1.0 | 0.020 ± 0.008*** | |
603 ± 204** (Km2) | ||||
CYP3A4.18 | 20.0 ± 2.7 (Km1) | 15.7 ± 4.5 | 0.090 ± 0.011 | |
172 ± 32 (Km2) | ||||
ATV 2-hydroxylation | ||||
CYP3A4.1 | 24.2 ± 7.6 | 6.6 ± 1.1 | 0.29 ± 0.08 | |
CYP3A4.16 | 87.4 ± 22.6** | 8.2 ± 1.9 | 0.10 ± 0.02* | |
CYP3A4.18 | 20.2 ± 6.8 | 3.8 ± 1.3 | 0.20 ± 0.11 | |
ATV 4-hydroxylation | ||||
CYP3A4.1 | 19.6 ± 4.0 | 16.1 ± 5.0 | 0.84 ± 0.29 | |
CYP3A4.16 | 65.4 ± 19.3** | 8.4 ± 1.4 | 0.14 ± 0.05* | |
CYP3A4.18 | 16.1 ± 3.4 | 11.1 ± 4.2 | 0.71 ± 0.31 | |
PTX 3′-p-hydroxylation | ||||
CYP3A4.1 | 2.9 ± 0.1 | 0.55 ± 0.06 | 0.19 ± 0.03 | |
CYP3A4.16 | 12.9 ± 2.4*** | 0.55 ± 0.13 | 0.04 ± 0.02*** | |
CYP3A4.18 | 2.7 ± 0.1 | 0.24 ± 0.07** | 0.09 ± 0.03** | |
DTX t-butyl hydroxylation | ||||
CYP3A4.1 | 2.5 ± 0.1 | 0.38 ± 0.01 | 0.16 ± 0.01 | |
CYP3A4.16 | 1.8 ± 0.2** | 0.26 ± 0.03** | 0.14 ± 0.01 | |
CYP3A4.18 | 2.3 ± 0.2 | 0.24 ± 0.04** | 0.10 ± 0.03* | |
IRN oxidation to NPC | ||||
CYP3A4.1 | 19.3 ± 2.7 | 1.4 ± 0.2 | 0.07 ± 0.02 | |
CYP3A4.16 | 34.0 ± 2.9** | 0.9 ± 0.4 | 0.03 ± 0.01* | |
CYP3A4.18 | 19.7 ± 2.8 | 0.7 ± 0.1* | 0.04 ± 0.01* | |
TFN t-butyl hydroxylation | ||||
CYP3A4.1 | 3.4 ± 0.3 | 3.4 ± 0.6 | 1.0 ± 0.2 | 218 ± 5 |
CYP3A4.16 | 3.5 ± 0.5 | 2.1 ± 0.1* | 0.6 ± 0.1* | 51 ± 8 |
CYP3A4.18 | 6.0 ± 1.2* | 3.1 ± 0.5 | 0.5 ± 0.1* | 311 ± 131 |
TFN N -demethylationb | ||||
CYP3A4.1 | 2.4 ± 0.5 | 2.2 ± 0.4 | 0.95 ± 0.25 | 629 ± 244 |
CYP3A4.16 | 2.1 ± 0.2 | 1.5 ± 0.3 | 0.72 ± 0.12 | 92 ± 8 |
CYP3A4.18 | 3.4 ± 0.3* | 1.9 ± 0.2 | 0.57 ± 0.10 |
↵* p < 0.05,
↵** p < 0.01, and
↵*** p < 0.001 versus the wild-type (Dunnett's multiple comparison test).
↵a For CBZ epoxidation, Km1 and Km2, Vmax2, and intrinsic clearance (Vmax2/Km2) values are indicated in each column.
↵b For TFN N-demethylation, kinetic profile of CYP3A4.18 was better fitted to the Michaelis-Menten model than to the substrate inhibition model.